"This minimally invasive tumor ablation technology will not damage adjacent important organs such as large blood vessels, bile ducts, nerves, and intestines!"
Alpmed has teamed up with authoritative experts in the field of cancer treatment to promote the latest technology in minimally invasive treatment for tumors: nanoKnife tumor ablation (also known as high-voltage pulse minimally invasive therapy) on the top national media platform, the People's Daily Health Client.
On December 30, 2021, the People's Daily Health Client live broadcast room welcomed three top experts in the field of minimally invasive treatment for tumors: Dr. Xiao Yueyong, Director of the Radiology Department of the First Medical Center of the Chinese PLA General Hospital, Dr. Chen Yongliang, Director of the Hepatobiliary and Pancreatic Department of the First Medical Center of the Chinese PLA General Hospital, and Dr. Wang Zhongmin, Director of the Interventional Radiology Department of Ruijin Hospital, Shanghai Jiaotong University School Of Medicine, to explain this new technology to netizens.
During the live broadcast, three experts systematically introduced knowledge about tumors and related treatments, emphasizing the difficulty of using thermal minimally invasive ablation technology for malignant tumors near the gallbladder and the hepatic portal region. The nanoKnife tumor ablation technology was highlighted for its unique treatment advantages, which can achieve selective ablation without damaging nearby organs or structures such as the gallbladder and hepatic portal region.
Director Xiao Yueyong stated that domestically produced nanoKnife technology and products are not inferior to imported ones in terms of advancedness and maturity.
The audience in the live broadcast asked questions actively, and three experts answered typical questions one by one.
As the live broadcast progressed, the number of online viewers in the live room increased rapidly, from 28,000 at the beginning to a peak of 280,000, with over 30,000 likes. The audience of the Health Times Weibo, which was broadcasted simultaneously, reached 107,000. Other synchronous live broadcast platforms such as Today's Headlines, Yizhibo, Sina News, Douyu, Huya, and Bilibili also had high click-through rates.
This live broadcast has attracted widespread attention, allowing more netizens to have a deeper understanding of tumor-related knowledge and nanoknife tumor ablation(steep pulse)minimally invasive therapy technology. It has also helped promote the popularization of domestic therapy technology and products, bringing high-end medical technology closer to the public!
Membership
